Atorvastatin-Medicated Dentifrice Significantly Inhibits CD4+ T Cell Proliferation: In vitro Pilot Study/ Pasta Dental Medicada con Atorvastatina Inhibe de Forma Significativa la Proliferacion de Celulas T CD4+: Un Estudio Piloto In vitro

Reports indicate that statins (cholesterol-lowering drugs), in addition to lowering cholesterol, have an immunomodulatory effect. This effect may be beneficial for the treatment of several diseases, including periodontal disease. The aim of the present study was to evaluate the immunomodulatory effe...

Full description

Saved in:
Bibliographic Details
Published in:International journal of morphology 2017-06, Vol.35 (2), p.394
Main Authors: Rosenberg, David R, Kernitsky, Jeremy R, Andrade, Catherine X, Ramirez, Valeria, Violant, Deborah, Nart, Jose
Format: Article
Language:Spanish
Subjects:
Analysis
Atorvastatin
Medical schools
T cells
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Reports indicate that statins (cholesterol-lowering drugs), in addition to lowering cholesterol, have an immunomodulatory effect. This effect may be beneficial for the treatment of several diseases, including periodontal disease. The aim of the present study was to evaluate the immunomodulatory effect of an atorvastatin-medicated dentifrice on CD4+ T cell proliferation. CD4+ T cell proliferation assays and peripheral blood mononuclear cell (PBMC) viability assays were conducted on PBMCs from healthy donors cultured under the following conditions: control, atorvastatin solution, atorvastatin-medicated dentifrice, and dentifrice without atorvastatin at concentrations of 1, 5, 10, 50 and 100 [micro]M. A Generalized Equation Estimation (GEE) model was used to analyze concentration versus proliferation and concentration versus percentage of dead cells within each group evaluated. Atorvastatin-medicated dentifrice (p-value
ISSN:0717-9367